Wang et al. (2019) explored the effects of LC1405, a novel H3R antagonist, on cognitive deficits caused by Aβ in a mouse model of Alzheimer’s disease (APP/PS1). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.